Johns Hopkins Medicine has been awarded more than $18 million from the Defense Advanced Research Projects Agency (DARPA) to lead a multi-institutional effort to develop a novel extracorporeal membrane oxygenation (ECMO) and advanced life-support system device. ECMO devices assist patients by enabling heart and lung function when their organs are too damaged or weak to function normally.
Your privacy is our priority
- Hosted on Secure cloud-based hosting
- SOC II Type 1
- HIPAA compliant
- 2FA authentication
- End-to-end data encryption
- Your health data will not be sold or used without your consent. Ever.
